- Home
- RXRX vs CLM Comparison
RXRX vs CLM Comparison
Compare RXRX & CLM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RXRX
- CLM
- Stock Information
- Founded
- RXRX 2013
- CLM 1987
- Country
- RXRX United States
- CLM United States
- Employees
- RXRX N/A
- CLM N/A
- Industry
- RXRX Biotechnology: Pharmaceutical Preparations
- CLM Finance/Investors Services
- Sector
- RXRX Health Care
- CLM Finance
- Exchange
- RXRX Nasdaq
- CLM Nasdaq
- Market Cap
- RXRX 2.0B
- CLM 2.0B
- IPO Year
- RXRX 2021
- CLM N/A
- Fundamental
- Price
- RXRX $5.25
- CLM $8.23
- Analyst Decision
- RXRX Buy
- CLM
- Analyst Count
- RXRX 5
- CLM 0
- Target Price
- RXRX $7.00
- CLM N/A
- AVG Volume (30 Days)
- RXRX 32.1M
- CLM 1.4M
- Earning Date
- RXRX 08-07-2025
- CLM 01-01-0001
- Dividend Yield
- RXRX N/A
- CLM 18.74%
- EPS Growth
- RXRX N/A
- CLM N/A
- EPS
- RXRX N/A
- CLM N/A
- Revenue
- RXRX $59,790,000.00
- CLM N/A
- Revenue This Year
- RXRX $23.51
- CLM N/A
- Revenue Next Year
- RXRX $53.87
- CLM N/A
- P/E Ratio
- RXRX N/A
- CLM N/A
- Revenue Growth
- RXRX 29.32
- CLM N/A
- 52 Week Low
- RXRX $3.79
- CLM $6.25
- 52 Week High
- RXRX $12.36
- CLM $8.84
- Technical
- Relative Strength Index (RSI)
- RXRX 55.15
- CLM 73.29
- Support Level
- RXRX $4.91
- CLM $8.08
- Resistance Level
- RXRX $5.44
- CLM $8.19
- Average True Range (ATR)
- RXRX 0.36
- CLM 0.09
- MACD
- RXRX 0.01
- CLM 0.01
- Stochastic Oscillator
- RXRX 72.37
- CLM 100.00
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
About CLM Cornerstone Strategic Value Fund Inc. New
Cornerstone Strategic Value Fund Inc is a closed-end management investment company. The fund's objective is to seek long-term capital appreciation through investments in equity securities of U.S. and non-U.S. companies. It invests in various sectors, which include financials, information technology, healthcare, consumer discretionary, industrials, utilities, energy, telecommunication services, materials, and other sectors.